At the same time although these CD56+ cells demonstrate cytotoxic activity against MM cell line [102], they exhibit low expression of CD16a (FcγRIIIA) compared to CB-NK cells, which limits their ADCC [103,104]. Here, FCGR3A is linked to Miyoshi myopathy.